Drug and pharmaceutical recalls

354 federal recalls in the last 12 months. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.

Recent recalls

Page 9 of 12
  • Cipla cinacalcet tablets recalled for N-nitroso impurity above limit

    Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain higher-than-acceptable levels of a chemical impurity called N-Nitroso Cinacalcet. The affected tablets were distributed nationwide. This is a manufacturing quality issue; no injuries have been reported.

    ModerateFDAApr 22, 2026Cipla3 products

  • Teva clonidine patches recalled for unapproved raw material

    Teva Pharmaceuticals is recalling certain Clonidine Transdermal System patches (0.1 mg/day) because they were manufactured using an unapproved raw material that does not meet FDA standards. The affected patches were distributed in the U.S. The company and FDA are working to ensure the product is removed from use.

    ModerateFDAApr 15, 2026Teva3 products

  • Check GE Healthcare Omnipaque injection lot numbers

    GE Healthcare has recalled specific lots of Omnipaque (iohexol) injection, a contrast dye used in medical imaging, because some vials may contain visible particles. This could affect the safety of the procedure if the contaminated solution is used.

    ModerateFDAApr 15, 2026GE Healthcare2 products

  • Teva isotretinoin capsules recalled for potency errors

    Teva is recalling two strengths of isotretinoin capsules, 30 mg and 40 mg, because some capsules may be stronger or weaker than the labeled amount. The recall covers 10-count prescription packs distributed in Florida, Ohio, Puerto Rico and Mississippi, and no injuries have been reported.

    ModerateFDAApr 15, 2026Teva2 products

  • Xanax XR 3 mg tablets recalled for failed dissolution

    Viatris is recalling one lot of Xanax XR (alprazolam) 3 mg extended-release tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This affects only lot #8177156 with an expiration date of 02/28/2027, distributed nationwide. No injuries have been reported.

    ModerateFDAApr 15, 2026Viatris

  • Preferred Pharmaceuticals eye drops recalled for lack of sterility assurance

    Preferred Pharmaceuticals' Artificial Tears Lubricant Eye Drops in 0.5 oz bottles may not be sterile due to a manufacturing issue. The FDA is recalling specific lots because sterility cannot be assured. No injuries have been reported.

    ModerateFDAApr 15, 2026Preferred Pharmaceuticals

  • Fagron IV norepinephrine and vancomycin bags recalled for sterility concerns

    Fagron Compounding Services is recalling five premixed IV bags in 0.9% sodium chloride: norepinephrine bitartrate (16 mg and 32 mg per 250 mL) and vancomycin (1 g, 1.25 g and 1.5 g per 250 mL). The bags were made by Fagron Sterile Services in Wichita, Kansas, and sold nationwide, and the company cannot assure they are sterile. A blue break-off part on the administration port could also detach. No injuries have been reported.

    SeriousFDAApr 15, 2026Fagron Compounding Services5 products

  • Fresenius Kabi IV saline and dextrose bags recalled over sterility

    Fresenius Kabi is recalling 14 sodium chloride and dextrose IV fluid bags because the company cannot assure they are sterile. The products were sold under the Fresenius Kabi, BD and Fresenius Medical Care names and were distributed nationwide, to Alaska and to Puerto Rico. No injuries have been reported.

    ModerateFDAApr 15, 2026Fresenius Kabi14 products

  • Cipla lanreotide injection recalled for sterility assurance concern

    Cipla is recalling two versions of its lanreotide injection, 120 mg/0.5 mL pre-filled syringes, sold nationwide. The recall was prompted by an FDA observation at the contract manufacturing site about visual inspection procedures, so the product cannot be assured to be sterile. No injuries have been reported.

    ModerateFDAApr 15, 2026Cipla2 products

  • Stop using Blaine Labs wound care gel

    Blaine Labs is recalling three lot numbers of Revitaderm and Tridergel wound care gel (1 oz. and 3 oz. bottles/tubes) because they may contain Lysinibacillus fusiformis, a bacterium found in the environment. The affected products were distributed to healthcare providers only, not sold in stores. No injuries have been reported so far.

    ModerateFDAApr 8, 2026Blaine Labs

  • Amneal magnesium sulfate IV bag recalled for tranexamic acid mix-up

    Some cartons of Amneal Magnesium Sulfate IV bags were mislabeled and contained Tranexamic Acid (a different medication) instead. This mix-up affects lot AH250162 with an expiration date of 8/31/2027. The error was discovered before the product reached patients.

    SeriousFDAApr 8, 2026Amneal Pharmaceuticals

  • Appco Pharma prazosin capsules recalled for nitrosamine impurity

    Appco Pharma LLC is recalling prazosin hydrochloride 1mg capsules (100-count bottles) because they may contain higher-than-acceptable levels of a nitrosamine impurity. This impurity was detected during manufacturing quality checks. The recall affects specific lot numbers distributed nationwide.

    ModerateFDAApr 8, 2026Appco Pharma3 products

  • Walgreens, Good Sense and more eye drops recalled for sterility

    K.C. Pharmaceuticals is recalling eight sterile eye drop products because the company cannot confirm they are sterile. The drops were sold under store and pharmacy brands including Best Choice, Walgreens, GERI CARE, LEADER, Good Sense, Industrial Eye Relief and Rugby. No injuries have been reported.

    ModerateFDAApr 8, 2026K.C. Pharmaceuticals8 products

  • Amneal tramadol tablets recalled for impurity out of specification

    Amneal Pharmaceuticals is recalling specific lots of tramadol 50 mg tablets because they contain higher-than-allowed levels of a chemical impurity called N-nitroso-desmethyl-tramadol (NDSRI). The impurity was discovered during stability testing of tablets nearing the end of their shelf life. No injuries have been reported.

    ModerateFDAApr 8, 2026Amneal Pharmaceuticals

  • Alembic bromfenac eye drops recalled for failed impurity testing

    Alembic Pharmaceuticals is recalling specific lots of Bromfenac Ophthalmic Solution 0.07% because the medication failed purity and degradation tests during stability testing at 20 months. The affected eye drops may contain higher-than-acceptable impurity levels, which could affect safety and effectiveness.

    ModerateFDAApr 8, 2026Alembic Pharmaceuticals

  • Stop using recalled Meclizine Hydrochloride tablets

    American Health Packaging is recalling specific batches of Meclizine Hydrochloride 12.5 mg tablets because they failed to meet required tablet specifications. The affected product is Lot #1024852 with an expiration date of 9/30/2026. No injuries have been reported.

    ModerateFDAApr 1, 2026Amerisource

  • Stop using Teva Octreotide Acetate injection

    Teva Pharmaceuticals is recalling specific lots of Octreotide Acetate injectable suspension due to sterility concerns identified at the manufacturing facility. The FDA found quality system deficiencies that could affect the safety of the medication.

    ModerateFDAApr 1, 2026Teva3 products

  • Macleods levothyroxine tablets recalled for subpotency

    Macleods Pharma USA is recalling Levothyroxine Sodium Tablets USP 150 mcg because they may contain less active ingredient than labeled. This means the medication may not work as intended to treat thyroid conditions. The affected lot is 16240062A with an expiration date of March 2026.

    ModerateFDAApr 1, 2026MacLeods Pharma

  • Stop using recalled CUROSURF lung surfactant

    Chiesi USA is recalling specific lots of CUROSURF, a medication given to premature infants to help them breathe. The company cannot confirm that all vials are sterile, which means they may be contaminated. No infections have been reported so far.

    ModerateFDAApr 1, 2026Chiesi

  • Stop using Radnostix Gelatin Capsule Pack

    Radnostix Gelatin Capsule Packs used with Sodium Iodide I-131 Kit have failed quality specifications. The affected capsules may not perform as intended. Three specific lots distributed nationwide are involved.

    ModerateFDAApr 1, 2026Radnostix

  • Kian Pee Wan capsules recalled for undeclared dexamethasone

    Kian Pee Wan capsules, sold online as a dietary supplement for weight gain and appetite, contain two hidden prescription drugs: dexamethasone (a corticosteroid) and cyproheptadine (an antihistamine). These drugs were not listed on the label. Taking these undeclared drugs can cause serious health problems including infections, high blood sugar, psychiatric issues, and withdrawal symptoms if stopped abruptly.

    SeriousFDAMar 30, 2026Buy-herbal.com

  • Apotex brimonidine/timolol eye drops recalled for lack of sterility assurance

    Apotex Corp. is recalling specific lots of brimonidine tartrate/timolol maleate eye drops because the manufacturer cannot confirm the product was sterilized properly. The affected lots are VJ8599 (expires 09/30/2026) and VL1668 (expires 01/31/2027). No infections or injuries have been reported so far.

    ModerateFDAMar 25, 2026Apotex

  • Stop using Somerset Therapeutics dexamethasone injection

    Somerset Therapeutics is recalling one lot of dexamethasone sodium phosphate injection because testing found impurity levels above acceptable limits as the product approached its expiration date. The affected lot (A240421, expiring 07/31/2026) was distributed nationwide. No injuries have been reported.

    ModerateFDAMar 25, 2026Somerset Therapeutics

  • Annora Pharma pitavastatin 2 mg tablets recalled for foreign tablet

    A 1 mg Pitavastatin tablet was found mixed into a bottle labeled as containing 2 mg tablets. This occurred in one lot (A252487) distributed in Tennessee. Taking the wrong dose by mistake could affect how well your cholesterol medication works.

    ModerateFDAMar 25, 2026Annora Pharma

  • Strides Pharma children's ibuprofen recalled for foreign substance

    Strides Pharma Children's Ibuprofen Oral Suspension (100 mg per 5 mL) has been recalled because some bottles contain gel-like masses and black particles. The affected bottles are 4 FL OZ (120 mL) size with lot numbers 7261973A or 7261974A, expiring 01/31/2027. No injuries have been reported.

    ModerateFDAMar 25, 2026Strides

  • Stop using Amneal Magnesium Sulfate IV bags

    One lot of Amneal Magnesium Sulfate in Water for Injection IV bags was found to contain the wrong medication—Tranexamic Acid—inside the packaging. This mix-up affects hospitals that received the product between late December 2025 and late February 2026. No patients have been harmed so far.

    SeriousFDAMar 24, 2026Amneal Pharmaceuticals

  • Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

    Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

    FDAMar 18, 2026Zydus

  • Amnesteem isotretinoin capsules recalled for failed dissolution

    Mylan Pharmaceuticals is recalling specific lots of Amnesteem (isotretinoin) 40 mg capsules because they failed to meet dissolution specifications—meaning the medication may not break down and be absorbed by your body as intended. This could affect how well the medicine works. The recall affects two lots (3116110 and 3116130) with an expiration date of July 2026.

    ModerateFDAMar 11, 2026Mylan

  • MR. 7 SUPER 700000 capsules recalled for undeclared sildenafil, tadalafil

    MR. 7 SUPER 700000 capsules contain hidden prescription drugs—sildenafil and tadalafil—that are not listed on the label. These are serious medications that can interact with other drugs and cause health problems. The product was sold without FDA approval.

    SeriousFDAMar 11, 2026Stuffby Nainax

  • Mojo Max Fusion XXX recalled for undeclared sildenafil and tadalafil

    Mojo Max Fusion XXX capsules contain hidden prescription drugs—sildenafil and tadalafil—that were not listed on the label. These are potent medications that can cause serious health problems, especially if you take other drugs or have certain heart or blood pressure conditions. The FDA has not approved this product for sale.

    SeriousFDAMar 11, 2026Mohamed Hagar

Explore other recall topics